Ma. Azrin et al., LOCAL-DELIVERY OF C-MYB ANTISENSE OLIGONUCLEOTIDES DURING BALLOON ANGIOPLASTY, Catheterization and cardiovascular diagnosis, 41(3), 1997, pp. 232-240
Intraluminal delivery of antisense oligonucleotides to c-myb was asses
sed following balloon angioplasty in swine peripheral arteries, Succes
sful delivery and intramural persistence of oligonucleotide for over 2
4 h were demonstrated following angioplasty with hydrogel balloons coa
ted with P-32-labeled antisense. Delivery of fluorescein-labeled antis
ense demonstrated further localization within the arteria( media and i
ntracellularly, Preliminary in vitro studies demonstrated the feasibil
ity of inhibition of porcine lymphocyte proliferation using the murine
antisense to c-myb, Twelve iliac or carotid arteries underwent angiop
lasty with antisense-coated balloons, while the contralateral vessels
underwent angioplasty with the same-sized balloons coated with the com
plementary sense strand. Six to seven days later, dilated arterial seg
ments were surgically isolated, In 10 of 12 vessel pairs, antisense-tr
eated vessels demonstrated less cellular proliferation than did contra
lateral sense-treated vessels, as assessed by quantitative immunohisto
chemical staining of proliferating cell nuclear antigen, and smooth mu
scle cell proliferation was reduced 18% in antisense-treated vessels c
ompared to the contralateral sense-treated vessels (PCNA-positive nucl
ear area: 7.7 +/- 4.9% vs, 9.3 +/- 5.2%, P < 0.04). Intraluminal deliv
ery of antisense oligonucleotides to c-myb is feasible with a catheter
-based system and may reduce smooth muscle cell proliferation followin
g arterial injury. (C) 1997 Wiley-Liss, Inc.